Skip navigation



Avacta Group PLC and Tufts University School of Medicine Collaborate to Develop Novel Class of Drug Conjugate

Drug conjugate combines Avacta’s Affimer technology with drug conjugates developed at Tufts. More »
30 July 2018

Partnering Opportunity - Novel Model for Assessing Corneal Drug Delivery

Researchers at the University of Birmingham seek collaborators to further validate their ex vivo corneal model to rapidly assess ocular drug delivery More »
30 July 2018

TTP PLC Completes Expansion of Life Sciences Lab Facility for Desktop Biology Programmes

Dedicated facility developed in response to increasing demand for product development projects in diagnostics, R&D and bioprocess. More »
30 July 2018

AMSBIO has Announced an Exosome Isolation, Manufacturing and Characterisation Service

AMSBIO has announced an exosome isolation, manufacturing and characterization service to enable R&D groups to accelerate their discovery and development activities. More »
23 July 2018

Isogenica Licenses CIS Display Technology to Aro Biotherapeutics for Centyrin-Based Biopharmaceutical Development

Isogenica Ltd today announced that it has signed a new licensing agreement with Aro Biotherapeutics Company (Aro) of Philadelphia. USA, that will leverage each other’s strengths in recombinant protein technologies and biopharmaceutical development. More »
23 July 2018

Endomag Raises $10 million USD (£8M GBP) to Establish a New Standard of Breast Cancer Care

Surgical guidance company, Endomagnetics Ltd (Endomag), today announced that it has raised $10 million USD (£8M GBP) Series C funding, led by Draper Esprit. This investment brings total funding for Endomag to over $22 million USD (£17m GBP) and will enable the company to significantly expand its capabilities, with the aim of treating more cancer patients around the world. More »
23 July 2018

2018 CRACK IT Challenges Announced

The 2018 CRACK IT Challenges are now live. This year's competition consists of three Challenges identified jointly by the NC3Rs and Sponsors. Funding is provided by the NC3Rs with co-funding provided by EPSRC (RaTS) and in-kind contributions are provided the Sponsors. There are four Sponsors (Galvani Bioelectronics, GSK, MRC Harwell Institute and Sanofi Pasteur EU). More »
20 July 2018

Domainex Opens for Business in Boston and San Diego

Domainex Ltd, Europe’s fastest growing drug discovery service company, is pleased to announce its expansion to the US with the appointment of a new business development team and the opening of East and West coast offices in Boston, MA and San Diego, CA. More »
19 July 2018

Owlstone Medical Appoints Five Leading Experts to Scientific Advisory Board

Additions form a key strategic resource to advise on Breath Biopsy platform, product, and study development. More »
19 July 2018

AMSBIO has Introduced New Powerful CRISPR/Cas9 Gene Editing Kits

AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications. More »
18 July 2018

<< Previous   Page 2 of 45   Next >>